Neonode Inc. filed its third-quarter 2026 earnings release on November 12, 2026, reporting financial results for the three and nine months ended September 30, 2026.

Key Highlights

  • Q3 revenue up 24.4%: Revenues from continuing operations were $0.5 million for the three months ended September 30, 2026, a 24.4% increase compared to the same period in 2025.
  • Q3 operating loss: Loss from continuing operations was $1.1 million, or $0.07 per share, compared to income of $13.9 million, or $0.83 per share, in Q3 2025, which included a $15.5 million net gain from a patent assignment.
  • Operating expenses declined: Q3 2026 operating expenses from continuing operations were $1.8 million, a decrease of 13.2% compared to the same period in 2025.
  • MultiSensing licensing surged: According to the filing, MultiSensing licensing revenue "more than quadrupled" in Q3 2026 compared with Q3 2025.
  • Cash and receivables: Cash and accounts receivable totaled $20.2 million as of September 30, 2026, compared to $25.8 million as of December 31, 2025.
  • Nine-month revenue growth: Revenues from continuing operations for the nine months ended September 30, 2026 were $1.6 million, an increase of 5.4% compared to the same period in 2025.

Neonode Q3 2026 Results: Revenue Growth Alongside Ongoing Operating Loss

Neonode Inc. (NASDAQ:NEON), reporting from Stockholm, disclosed its financial results for the quarter and nine months ended September 30, 2026. According to the filing, revenues from continuing operations for Q3 2026 were $0.5 million, driven by license revenues of $0.4 million, up 9.4% year over year, and non-recurring engineering revenues of $91,000, an increase of 279.2% compared to the same period in 2025. The company attributed the engineering revenue increase to higher project deliveries and the license revenue growth to new license agreements.

The filing reported a Q3 2026 loss from continuing operations of $1.1 million, or $0.07 per share. The company noted that the prior-year Q3 figure of $13.9 million income included a one-time $15.5 million net gain from a patent assignment, and that the comparison "should not be interpreted as a corresponding deterioration in the underlying business," according to CEO Daniel Alexus. Operating expenses fell 13.2% in Q3 2026, with the company attributing the decrease to lower payroll and related costs and lower professional fees. Cash used by operations was $1.6 million in Q3 2026, compared to $1.5 million in Q3 2025.

For the nine-month period, the filing disclosed a loss from continuing operations of $5.1 million, or $0.31 per share, against income of $10.2 million, or $0.60 per share, in the same 2025 period, again reflecting the prior-year patent assignment gain. Nine-month operating expenses were $7.3 million, an increase of 0.2% compared to 2025. Working capital from continuing operations was $19.2 million as of September 30, 2026, compared to $24.1 million as of December 31, 2025. The CEO's comments, as quoted in the filing, acknowledged that "our revenue base is not yet sufficient to achieve profitability."

What Was Disclosed

Neonode reported Q3 2026 and nine-month 2026 financial results, showing revenue growth and reduced operating expenses against a backdrop of ongoing operating losses, with the year-over-year earnings comparison affected by a non-recurring 2025 patent assignment gain of $15.5 million.